Why the study?
Does nicardipine alter acute cardiovascular hemodynamics compared to placebo or nifedipine in normal subjects?
Does nicardipine alter acute cardiovascular hemodynamics compared to placebo or nifedipine in normal subjects?
Nicardipine produces acute dose-dependent hemodynamic effects similar to nifedipine in normal subjects.
Answers are grounded in this paper and cite their sources.
Nicardipine dosing informs acute BP management choices; confirms comparable effects to nifedipine in healthy subjects.
1 The acute cardiovascular response to nicardipine was investigated using non invasive techniques in normal subjects. 2 In six subjects, i.v. nicardipine in an increasing dose (0.5-20 mg) was compared with saline, under double-blind conditions. A dose related increase in heart rate and fall in blood pressure were found. Pre-ejection period (PEP) and PEP/left ventricular ejection time (LVET) ratio of the systolic time intervals were shortened in a clearly dose related manner. Total electromechanical systole index (QS2 I) was decreased and LVET index prolonged. 3 In four subjects increasing oral doses (10-40 mg) of nicardipine, administered in a randomized double-blind placebo control design, demonstrated the same pattern, marked changes being found with the 40 mg dose. 4 Comparison with nifedipine in a double-blind-placebo controlled balanced trial in six subjects confirmed that 40 mg nicardipine and 20 mg nifedipine exhibited similar effects. Maximum response was reached between 0.5 and 1.5 h, and changes in some cardiovascular variables were still evident at 3 h.
No takes yet. Share an insight, caveat, or question.
Iliopoulou et al. (1983) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: